Cathepsin-D and TNF-alpha in bladder cancer

Area of Science:

• Oncology
• Immunology
• Parasitology

Background:

• Bladder cancer is a significant global health concern.
• Urinary tract bilharziasis is endemic in many regions and is associated with an increased risk of bladder cancer.
• Tumor necrosis factor alpha (TNF-alpha) and Cathepsin-D are investigated as potential biomarkers in various cancers.

Purpose of the Study:

• To evaluate serum tumor necrosis factor alpha (TNF-alpha) and cytosolic Cathepsin-D as potential prognostic biomarkers for bladder cancer.
• To assess the correlation of these markers with tumor stage, grade, and bilharzial involvement.

Main Methods:

• Serum levels of TNF-alpha and cytosolic Cathepsin-D were measured in 34 healthy controls, 35 patients with urinary tract bilharziasis, and 93 bladder cancer patients.
• Bladder cancer patients included operable and non-operable cases.
• Statistical analyses were performed to assess correlations with clinical parameters.

Main Results:

• Both TNF-alpha and Cathepsin-D levels were found to be elevated in bladder cancer patients compared to controls.
• Neither TNF-alpha nor Cathepsin-D demonstrated a significant correlation with tumor stage or grade.
• No association was found between these markers and bilharzial ova presence or lymph node involvement.

Conclusions:

• While elevated in bladder cancer, serum TNF-alpha and cytosolic Cathepsin-D do not appear to be reliable prognostic markers.
• Further research is needed to identify accurate biomarkers for bladder cancer prognosis, especially in regions endemic for bilharziasis.